Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice Scandinavia 247 Nov 15, 2019 18.00 +0.84   
 2cureX AB 2CUREX Nov 15, 2019 14.10 -1.40   
 A3 Allmänna IT- och Telekomakt ATRE Nov 15, 2019 16.00 0.00   
 AAC Clyde Space AB (publ) AAC Nov 15, 2019 4.93 +4.12   
 AAK AAK Nov 15, 2019 181.05 +0.84   
 ABB ABB Nov 15, 2019 213.60 +0.75   
 Abelco Investment Group ABIG Nov 15, 2019 0.13 -0.77   
 ABG Sundal Collier Holding ASCO 0.00 0.00   
 Absolent Group ABSO Nov 15, 2019 384.00 -2.29   
 Absolicon ABSL Nov 15, 2019 140.00 -2.78   
 AcadeMedia ACAD Nov 15, 2019 51.80 -0.77   
 Acarix ACARIX Nov 15, 2019 1.80 +5.88   
 Acconeer ACCON Nov 15, 2019 20.15 +1.36   
 Acosense ACOS Nov 15, 2019 2.28 +2.70   
 AcouSort ACOU Nov 15, 2019 10.75 +10.14   
 Acrinova ACRI Nov 15, 2019 22.60 -0.88   
 Actic Group ATIC Nov 15, 2019 21.60 -1.82   
 Active Biotech ACTI Nov 15, 2019 2.74 +3.40   
 AcuCort ACUC Nov 15, 2019 2.55 -0.78   
 Adapteo ADAPT Nov 15, 2019 112.66 -0.56   
 AdCityMedia ACM Nov 15, 2019 119.50 +1.27   
 AdderaCare ADDERA Nov 15, 2019 5.22 +0.38   
 AddLife B ALIFB Nov 15, 2019 243.00 -1.22   
 Addnode Group B ANODB Nov 15, 2019 170.50 -1.73   
 Addtech B ADDTB Nov 15, 2019 267.00 +0.19   
 ADDvise Group A ADDVA Nov 15, 2019 1.08 -1.82   
 ADDvise Group B ADDVB Nov 15, 2019 0.76 +9.35   
 Adevinta B ADEBO Nov 15, 2019 100.60 0.00   
 Advanced Stabilized Technologi ASTGB Nov 15, 2019 3.25 -3.27   
 Advenica ADVE Nov 15, 2019 3.12 +1.96   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK